Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Boston Scientific News

    72,74 $ -0,59% -0,43 $
    In : 67,931 € | 16:28:42 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 884113
    ISIN: US1011371077
    US-Symbol: BSX
    Typ: Aktie
    Werbung
    Weiter abwärts?
    Short Hebel 17,67
    ME834C

    Boston Scientific News

    27.04.24 - Der Aktionär
    Olivier Litzka von Andera Partners: "Über vier Milliarden Euro under Management"
    24.04.24 - PR Newswire
    Boston Scientific Announces Results for First Quarter 2024
    Boston Scientific Announces Results for First Quarter 2024 PR Newswire
    08.04.24 - PR Newswire
    Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
    Boston Scientific Initiates NAVIGATE-​PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module PR Newswire
    01.04.24 - PR Newswire
    Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
    Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results PR Newswire
    01.03.24 - PR Newswire
    Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
    Boston Scientific Receives FDA Approval for the AGENT™ Drug-​Coated Balloon PR Newswire
    27.02.24 - PR Newswire
    Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes
    Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes PR Newswire
    22.02.24 - PR Newswire
    Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes
    Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes PR Newswire
    05.02.24 - PR Newswire
    Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference
    Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference PR Newswire
    31.01.24 - PR Newswire
    Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
    Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 PR Newswire
    31.01.24 - PR Newswire
    Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
    Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System PR Newswire
    31.01.24 - wallstreet:online Zentralredaktion
    Ihre wichtigsten Termine: Zahlen von: Boeing, Mastercard, Novo Nordisk, Novartis und Qualcomm
    Gut geplant in den Tag. Mit dem w:o-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
    26.01.24 - PR Newswire
    AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
    AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
    08.01.24 - PR Newswire
    ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
    ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc. PR Newswire
    08.01.24 - PR Newswire
    Boston Scientific Announces Agreement to Acquire Axonics, Inc.
    Boston Scientific Announces Agreement to Acquire Axonics, Inc. PR Newswire
    05.01.24 - PR Newswire
    Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results PR Newswire
    28.12.23 - PR Newswire
    Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation
    Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-​Line Treatment for Persistent Atrial Fibrillation PR Newswire
    17.11.23 - PR Newswire
    Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
    Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. PR Newswire
    01.11.23 - PR Newswire
    Boston Scientific to Participate in Stifel's 2023 Healthcare Conference
    Boston Scientific to Participate in Stifel's 2023 Healthcare Conference PR Newswire
    26.10.23 - PR Newswire
    BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023
    BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023 PR Newswire
    25.10.23 - PR Newswire
    Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
    Boston Scientific AGENT™ Drug-​Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 -5,94%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »